AFM24
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AFM24, covering 2024-08-29 to 2025-08-20. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers [Phase 1, Phase 2]